Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpire Healthcare Regulatory News (SPI)

Share Price Information for Spire Healthcare (SPI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 232.00
Bid: 233.00
Ask: 234.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.429%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 232.00
SPI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - SPIRE HEALTHCARE GROUP PLC

16 Nov 2017 11:54

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose SPIRE HEALTHCARE GROUP PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 15 November 2017
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? MEDICLINIC INTERNATIONAL PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 1p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 2,416,593 0.60% 1,601,953 0.40%
(2) Cash-settled derivatives:
931,840 0.23% 890,257 0.22%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
(4)
TOTAL: 3,348,433 0.83% 2,492,210 0.62%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
1p ordinary Purchase 158 2.9940 GBP
1p ordinary Purchase 284 2.9860 GBP
1p ordinary Purchase 284 2.9856 GBP
1p ordinary Purchase 372 2.9610 GBP
1p ordinary Purchase 609 2.9680 GBP
1p ordinary Purchase 3,922 2.9626 GBP
1p ordinary Purchase 4,271 2.9658 GBP
1p ordinary Purchase 5,311 2.9603 GBP
1p ordinary Purchase 5,409 2.9714 GBP
1p ordinary Purchase 34,596 2.9685 GBP
1p ordinary Sale 284 2.9860 GBP
1p ordinary Sale 363 2.9680 GBP
1p ordinary Sale 1,192 2.9600 GBP
1p ordinary Sale 3,734 2.9658 GBP
1p ordinary Sale 5,561 2.9660 GBP
1p ordinary Sale 14,425 2.9606 GBP

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
1p ordinary CFD Long 363 2.9679 GBP
1p ordinary CFD Long 1,192 2.9600 GBP
1p ordinary SWAP Long 1,690 2.9634 GBP
1p ordinary CFD Long 2,691 2.9386 GBP
1p ordinary CFD Long 3,734 2.9658 GBP
1p ordinary CFD Long 11,038 2.9689 GBP
1p ordinary SWAP Long 11,334 2.9660 GBP
1p ordinary CFD Short 246 2.9680 GBP
1p ordinary CFD Short 372 2.9610 GBP
1p ordinary SWAP Short 1,200 2.9715 GBP
1p ordinary SWAP Short 1,417 2.9718 GBP
1p ordinary CFD Short 1,444 2.9452 GBP
1p ordinary SWAP Short 3,516 2.9591 GBP
1p ordinary SWAP Short 4,773 2.9740 GBP
1p ordinary SWAP Short 34,596 2.9685 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 16 Nov 2017
Contact name: Jay Supaya
Telephone number: 020 7773 0635

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171116005720/en/

Copyright Business Wire 2017

Date   Source Headline
28th Mar 20241:54 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSNotice of Capital Markets Event
15th Mar 202410:07 amRNSDirector/PDMR Shareholding
1st Mar 20244:35 pmRNSTotal Voting Rights
29th Feb 20247:00 amRNSCFO transition
29th Feb 20247:00 amRNSFinal Results
13th Feb 20247:31 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSTotal Voting Rights and Capital
29th Jan 20247:00 amRNSNotice of Preliminary Results
11th Jan 20243:18 pmRNSBlock listing Interim Review
1st Dec 20237:00 amRNSTotal Voting Rights and Capital
1st Nov 20239:47 amRNSTotal Voting Rights
20th Oct 202311:21 amRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSAcquisition of Vita Health Group
2nd Oct 20232:57 pmRNSTotal Voting Rights
2nd Oct 20239:19 amRNSBlock listing Interim Review
14th Sep 20237:00 amRNSHalf-year Report
1st Sep 20233:52 pmRNSTotal Voting Rights
11th Aug 20238:15 amRNSHolding(s) in Company
10th Aug 20237:00 amRNSNotice of Interim Results
1st Aug 20239:04 amRNSTotal Voting Rights
13th Jul 20233:15 pmRNSDirector Declaration
11th Jul 20237:49 amRNSBlock listing Interim Review
1st Jun 20239:12 amRNSTotal Voting Rights
11th May 20232:20 pmRNSResults of 2023 Annual General Meeting
11th May 20237:00 amRNSAGM Statement
12th Apr 20234:22 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:04 pmRNSAnnual Financial Report
3rd Apr 20238:07 amRNSTotal Voting Rights
30th Mar 20233:18 pmRNSBlock listing Interim Review
30th Mar 20232:48 pmRNSDirector/PDMR Shareholding
16th Mar 202310:00 amRNSDirector/PDMR Shareholding
9th Mar 20239:18 amRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSFinal Results
28th Feb 20234:01 pmRNSDirector Declaration
9th Feb 20237:00 amRNSPreliminary Results Presentation – Change of Venue
1st Feb 202310:52 amRNSTotal Voting Rights
23rd Jan 20237:00 amRNSNotice of Preliminary Results
20th Jan 20239:30 amRNSDirector Declaration
12th Jan 20239:42 amRNSBlock listing Interim Review
3rd Jan 20232:00 pmRNSTotal Voting Rights
19th Dec 20227:00 amRNSAcquisition of The Doctors Clinic Group Limited
1st Dec 202210:02 amRNSTotal Voting Rights
1st Nov 20221:24 pmRNSTotal Voting Rights
14th Oct 202210:00 amRNSChanges to Board of Directors and committees
3rd Oct 20224:04 pmRNSTotal Voting Rights
30th Sep 20227:00 amRNSBlock Listing Six Monthly Return
8th Sep 20227:00 amRNSInterim Results
1st Sep 20229:51 amRNSTotal Voting Rights
23rd Aug 20222:55 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.